Skip to main content
. 2020 Mar 19;3:134. doi: 10.1038/s42003-020-0863-y

Fig. 1. Workflow of lung cancer and non-cancer controls used for developing a diagnostic model.

Fig. 1

Serum samples were obtained from 1698 lung cancer, 207 non-cancer patients in National Cancer Center biobank, and 1998 non-cancer participants in Yokohama Minoru Clinic. After excluding 132 samples from National Cancer Center biobank and 27 samples from Yokohama Minoru Clinic, the sample set was divided into two groups: the discovery set (N = 416) and validation set (N = 3328).